background: human chorionic gonadotropin (hcg) has been used as a replacement for the mid-cycle luteinizing hormone (lh) surge for several years. the recent arrival of recombinant dna technology has made recombinant hcg (rhcg) accessible. objective: to assess efficacy of rhcg compared to urinary hcg (uhcg) for triggering of ovulation and induction of final oocyte maturation in assisted reproduc...

background: there is an upward trend for parents to resort to assisted reproductive technology (art) treatment due to delayed childbirth or birth difficulties. objective: this study investigates the pregnancy health and birth outcomes of women who underwent art and analyzes the factors that influence birth weight to become<10 percentile when undergoing art. materials and methods: this study ana...

0

Established under the Assisted Human Reproduction (AHR) Act of 2004, Assisted Human Reproduction Canada [5] (AHRC), also known as the Assisted Human Reproduction Agency of Canada, was created in 2006 to oversee research related to reproductive technologies and to protect the reproductive rights [6] and interests of Canadian citizens. AHRC serves as a regulatory body for the development and use ...

Established under the Assisted Human Reproduction (AHR) Act of 2004, Assisted Human Reproduction Canada [5] (AHRC), also known as the Assisted Human Reproduction Agency of Canada, was created in 2006 to oversee research related to reproductive technologies and to protect the reproductive rights [6] and interests of Canadian citizens. AHRC serves as a regulatory body for the development and use ...